Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2019 | Light chain glycosylation provides diagnostic clues in CAD

Surbhi Sidana • 7 Dec 2019
ASH 2019
Anemias Cold Agglutinin Disease Non-Malignant

Primary cold agglutinin disease (CAD) is a rare form of autoimmune hemolytic anemia. Surbhi Sidana, MD, Mayo Clinic, Stanford, CA, outlines the study investigating the presence of post-translational glycosylation as a potential mechanism for IgM modification. Results show changes in the IgM immunoglobulin structure by post-translational glycosylation of light chains were significantly more common in patients with CAD compared with other IgM monoclonal gammopathies. The presence of light chain glycosylation can provide diagnostic clues and can be a potential therapeutic target. This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.

More from Surbhi Sidana

1:29
Managing toxicities associated with immunotherapy in multiple myeloma
Surbhi Sidana • 8 Dec 2023
1:43
Ide-cel therapy for multiple myeloma with renal impairment
Surbhi Sidana • 8 Dec 2023
3:09
An overview of the toxicities associated with immunotherapy in multiple myeloma
Surbhi Sidana • 8 Dec 2023
1:59
Real-world outcomes of ide-cel in heavily pre-treated R/R MM
Surbhi Sidana • 8 Dec 2023

Related Videos

2:01
The MDT in the new era of gene therapy for hemoglobinopathies
Mattia Algeri • 15 Apr 2024
2:38
Treosulfan vs busulfan conditioning in pediatric patients with non-malignant diseases
Rita Beier • 15 Apr 2024
3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
3:45
A 2-year analysis of the EBMT-SAAWP RACE trial: eltrombopag in aplastic anemia
Antonio Risitano • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals